Factory Direct Sale Ciprofloxacin Powder CAS 85721 -33-1 with Wholesale Price

Model NO.
TGY2023006080701
Service
OEM
Grade
Pharmaceutical Grade
MOQ
Any Quantitiy
Sample
Available
Shelf Life
24 Months Properly
Certificate
ISO9001:2008
Storage
Cool Dry Area
Test Method
USP;GMP
Molecular Weight
331.34
Molecular Formula
C17h18fn3o3
COA
Available
Assay
99%
Product Name
Ciprofloxacin
Appearance
White Powder
CAS No.
85721-33-1
Transport Package
Boil Bag
Specification
HPLC 99%
Trademark
TGY
Origin
Xi′an, Shaanxi, China (Mainland)
HS Code
29225090
Production Capacity
5000kg/Month
Reference Price
$ 27.00 - 45.00
Contact Us

Product Description

Factory Direct Sale Ciprofloxacin Powder CAS 85721-33-1 with Wholesale Price Factory Direct Sale Ciprofloxacin Powder CAS 85721-33-1 with Wholesale Price

Product Name Ciprofloxacin
CAS NO. 85721-33-1
Purity 99%
Density 1.461
Appearance and shape White powder


Factory Direct Sale Ciprofloxacin Powder CAS 85721-33-1 with Wholesale Price

Ciprofloxacin is used to treat or prevent certain infections caused by bacteria. Ciprofloxacin is also used to treat or prevent anthrax in people who may have been exposed to anthrax germs in the air. Ciprofloxacin is in a class of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections. Antibiotics will not work for colds, flu, or other viral infections.


Factory Direct Sale Ciprofloxacin Powder CAS 85721-33-1 with Wholesale Price

 

1. Ciprofloxacin HCl drug is used for the treatment of Bacterial infection of the Respiratory tract, UTI, Uncomplicated Cystitis in females, GI, Chronic Bacterial Prostatitis, CNS, Immunocompromised patients, Skin, Bone, and Joint Infections, Uncomplicated cervical, and urethral gonorrhea.

2. Ciprofloxacin HCl drug has in vitro activity against a wide range of gram-negative and gram-positive organisms.

3. Ciprofloxacin HCl drug inhibits bacterial DNA gyrase, an enzyme responsible for counteracting excessive supercoiling of DNA during replication or transcription. The mechanism of action of quinolones, including the Ciprofloxacin HCl drug, is different from that of other antimicrobial agents such as beta-lactams, macrolides, tetracyclines, or aminoglycosides; therefore, organisms resistant to these drugs may be susceptible to Ciprofloxacin HCl drug. There is no known cross-resistance between ciprofloxacin HCl drug and other classes of antimicrobials.

 

Pharmaceutical Intermediate

GOUV.NE, 2023